Form 8-K - Current report:
SEC Accession No. 0001437749-25-012153
Filing Date
2025-04-16
Accepted
2025-04-16 16:11:57
Documents
14
Period of Report
2025-04-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 FORM 8-K allr20250415_8k.htm   iXBRL 8-K 32215
  Complete submission text file 0001437749-25-012153.txt   175300

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA allr-20250416.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE allr-20250416_def.xml EX-101.DEF 11804
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE allr-20250416_lab.xml EX-101.LAB 15848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE allr-20250416_pre.xml EX-101.PRE 12019
16 EXTRACTED XBRL INSTANCE DOCUMENT allr20250415_8k_htm.xml XML 2938
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 25842974
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)